Cargando…
Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305]
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264650/ https://www.ncbi.nlm.nih.gov/pubmed/27577017 http://dx.doi.org/10.1016/j.ebiom.2016.08.031 |
| _version_ | 1782500137475506176 |
|---|---|
| author | Fishel, Simon Baker, Deborah Elson, Janine Ragunath, Maha Atkinson, Glenn Shaker, Adel Omar, Ahmed Kazem, Rahnuma Beccles, Ashley Greer, Ian A. |
| author_facet | Fishel, Simon Baker, Deborah Elson, Janine Ragunath, Maha Atkinson, Glenn Shaker, Adel Omar, Ahmed Kazem, Rahnuma Beccles, Ashley Greer, Ian A. |
| author_sort | Fishel, Simon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5264650 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52646502017-02-01 Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] Fishel, Simon Baker, Deborah Elson, Janine Ragunath, Maha Atkinson, Glenn Shaker, Adel Omar, Ahmed Kazem, Rahnuma Beccles, Ashley Greer, Ian A. EBioMedicine Corrigendum Elsevier 2016-08-24 /pmc/articles/PMC5264650/ /pubmed/27577017 http://dx.doi.org/10.1016/j.ebiom.2016.08.031 Text en © 2016 The Authors |
| spellingShingle | Corrigendum Fishel, Simon Baker, Deborah Elson, Janine Ragunath, Maha Atkinson, Glenn Shaker, Adel Omar, Ahmed Kazem, Rahnuma Beccles, Ashley Greer, Ian A. Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] |
| title | Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] |
| title_full | Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] |
| title_fullStr | Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] |
| title_full_unstemmed | Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] |
| title_short | Corrigendum to “Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome” [EBioMedicine 10 (2016) 299-305] |
| title_sort | corrigendum to “precision medicine in assisted conception: a multicenter observational treatment cohort study of the annexin a5 m2 haplotype as a biomarker for antithrombotic treatment to improve pregnancy outcome” [ebiomedicine 10 (2016) 299-305] |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264650/ https://www.ncbi.nlm.nih.gov/pubmed/27577017 http://dx.doi.org/10.1016/j.ebiom.2016.08.031 |
| work_keys_str_mv | AT fishelsimon corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT bakerdeborah corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT elsonjanine corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT ragunathmaha corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT atkinsonglenn corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT shakeradel corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT omarahmed corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT kazemrahnuma corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT becclesashley corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 AT greeriana corrigendumtoprecisionmedicineinassistedconceptionamulticenterobservationaltreatmentcohortstudyoftheannexina5m2haplotypeasabiomarkerforantithrombotictreatmenttoimprovepregnancyoutcomeebiomedicine102016299305 |